Condition

Prediabetes is a warning shot — and it is reversible

Q: What A1C is considered prediabetes?

An A1C of 5.7% to 6.4% is the prediabetes range. Normal is below 5.7%; type 2 diabetes is 6.5% or higher. Diagnosis usually requires confirmation with a repeat test.

Q: Can prediabetes be reversed?

Yes. The Diabetes Prevention Program showed that 7% sustained weight loss with regular activity cut 3-year progression to type 2 diabetes by 58%. GLP-1 medications return the majority of patients with overweight/obesity and prediabetes to normal glycemia in clinical trials.

Q: How long do I have before prediabetes becomes diabetes?

Without intervention, roughly 5–10% of people with prediabetes progress to type 2 diabetes each year. Over a decade, the cumulative risk is approximately 50%. Early treatment dramatically reduces this.

Q: Should I take metformin for prediabetes?

Metformin is reasonable for higher-risk prediabetes — particularly BMI ≥35, age <60, prior gestational diabetes, or rising A1C despite lifestyle change. Lifestyle intervention is more effective in older adults; metformin is more effective in younger adults with obesity.

Q: Can I qualify for GLP-1 medication with prediabetes?

Yes, if your BMI is 27 or higher (since prediabetes is a weight-related condition that lowers the threshold) or 30 or higher without complications. Submit your intake and a clinician will evaluate.

Q: Does prediabetes cause symptoms?

Most people have no symptoms, which is why the CDC estimates 80% of cases go undiagnosed. Some people notice fatigue after meals, increased thirst, or skin changes like acanthosis nigricans (dark velvety patches on the neck or underarms).

Q: Will losing weight lower my A1C even without medication?

Yes. A 5–7% weight loss typically lowers A1C by 0.3–0.5 percentage points and substantially reduces diabetes risk. Larger losses (10–15%) often return A1C to the normal range.

A1C 5.7–6.4% means insulin resistance has already begun. The good news: roughly 5–7% sustained weight loss cuts the risk of progression to type 2 diabetes by more than half.

How prediabetes is diagnosed

Prediabetes is identified using one of three blood tests, repeated to confirm:

Test	Normal	Prediabetes	Type 2 diabetes
Hemoglobin A1C	<5.7%	5.7–6.4%	≥6.5%
Fasting plasma glucose	<100 mg/dL	100–125 mg/dL	≥126 mg/dL
2-hour OGTT	<140 mg/dL	140–199 mg/dL	≥200 mg/dL

The CDC estimates more than 96 million U.S. adults have prediabetes, and about 80% are unaware. Without intervention, roughly 5–10% per year progress to type 2 diabetes.

What is actually happening in the body

Prediabetes is the visible edge of insulin resistance — when muscle, liver, and fat cells respond less efficiently to insulin's signal to absorb glucose from the bloodstream. The pancreas compensates by producing more insulin, which works for a while but creates downstream effects:

Hyperinsulinemia promotes fat storage, particularly visceral fat, which itself worsens insulin resistance.
Beta-cell stress accumulates over years; eventually insulin production starts to fail and glucose rises into the diabetic range.
Vascular changes begin during prediabetes, not after diabetes onset. Cardiovascular risk is elevated even at A1C 5.8%.

Prediabetes is not "almost diabetes." It is a metabolic state in its own right with measurable consequences. Treating it early is much easier than reversing established type 2 diabetes.

Reversal pathways — what actually works

The Diabetes Prevention Program (DPP) is the foundational evidence base. In 3,234 adults with prediabetes:

Lifestyle intervention with 7% weight loss and 150 min/week of activity reduced 3-year diabetes risk by 58%.
Metformin reduced risk by 31%.
The lifestyle effect was largest in adults over 60 (71% reduction).

For people who also meet criteria for overweight/obesity, GLP-1 receptor agonists add a third tool. The STEP-1 prediabetes substudy found that 84% of participants with prediabetes treated with semaglutide 2.4 mg returned to normoglycemia at 68 weeks. SURMOUNT-1 showed similar effects with tirzepatide.

When GLP-1 medication is appropriate

For prediabetes specifically, current guidance supports GLP-1 therapy when:

BMI ≥ 27

Prediabetes is itself a weight-related complication that lowers the BMI threshold for pharmacotherapy.

Lifestyle has plateaued

If 3–6 months of structured lifestyle change has not produced ≥5% weight loss or normalized A1C, escalation is reasonable.

Cardiovascular risk is elevated

The SELECT trial showed cardiovascular benefit with semaglutide in adults with overweight/obesity and CV disease, regardless of diabetes status.

Family history

Strong family history of type 2 diabetes meaningfully raises personal risk and supports earlier intervention.

WeightlessRx clinicians review A1C and metabolic context as part of intake. See GLP-1 BMI eligibility for full criteria.

Practical lifestyle steps that move A1C

Lose 5–7% of body weight. This single intervention has the largest effect size in trials.
Walk 150+ minutes per week, ideally including 2–3 sessions after the largest meal of the day to blunt the glucose spike.
Resistance training 2x per week. Muscle is the main glucose sink; more muscle means better insulin sensitivity.
Mediterranean-style eating with intact carbohydrates, plenty of fiber, olive oil, fish, legumes, and modest red meat.
Sleep 7+ hours. Two nights of restricted sleep measurably worsens insulin sensitivity.
Reduce ultra-processed food, particularly sugar-sweetened beverages, which raise A1C independent of total calorie intake.

Frequently asked questions

What A1C is considered prediabetes?

An A1C of 5.7% to 6.4% is the prediabetes range. Normal is below 5.7%; type 2 diabetes is 6.5% or higher. Diagnosis usually requires confirmation with a repeat test.

Can prediabetes be reversed?

Yes. The Diabetes Prevention Program showed that 7% sustained weight loss with regular activity cut 3-year progression to type 2 diabetes by 58%. GLP-1 medications return the majority of patients with overweight/obesity and prediabetes to normal glycemia in clinical trials.

How long do I have before prediabetes becomes diabetes?

Without intervention, roughly 5–10% of people with prediabetes progress to type 2 diabetes each year. Over a decade, the cumulative risk is approximately 50%. Early treatment dramatically reduces this.

Should I take metformin for prediabetes?

Metformin is reasonable for higher-risk prediabetes — particularly BMI ≥35, age <60, prior gestational diabetes, or rising A1C despite lifestyle change. Lifestyle intervention is more effective in older adults; metformin is more effective in younger adults with obesity.

Can I qualify for GLP-1 medication with prediabetes?

Yes, if your BMI is 27 or higher (since prediabetes is a weight-related condition that lowers the threshold) or 30 or higher without complications. Submit your intake and a clinician will evaluate.

Does prediabetes cause symptoms?

Most people have no symptoms, which is why the CDC estimates 80% of cases go undiagnosed. Some people notice fatigue after meals, increased thirst, or skin changes like acanthosis nigricans (dark velvety patches on the neck or underarms).

Will losing weight lower my A1C even without medication?

Yes. A 5–7% weight loss typically lowers A1C by 0.3–0.5 percentage points and substantially reduces diabetes risk. Larger losses (10–15%) often return A1C to the normal range.

See if you qualify with WeightlessRx

U.S.-licensed clinicians review every intake. Direct-pay membership — medication, support, and shipping included.

Choose a plan

References

CDC National Diabetes Statistics Report, 2024.
Diabetes Prevention Program Research Group. NEJM 2002;346:393–403.
ADA Standards of Medical Care in Diabetes — 2025.
Davies MJ et al. STEP 2 trial. Lancet 2021;397:971–984.
Garvey WT et al. Two-year semaglutide effects on glycemia. Lancet 2022.
Knowler WC et al. 10-year follow-up DPP/DPPOS. Lancet 2009;374:1677–1686.

Editorial standards

Reviewed against current GLP-1 prescribing labeling, ADA Standards of Care, AACE/Endocrine Society guidelines, and peer-reviewed clinical literature. Educational content — not a substitute for individualized medical advice. See our medical review policy.